← Back to Search

Mobile Contingency Management for Smoking Cessation (P3 Trial)

N/A

Recruiting

Led By Darla E. Kendzor, PhD

Research Sponsored by University of Oklahoma

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

are ≥ 18 years of age

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 26 weeks post-quit-date

Awards & highlights

P3 Trial Summary

This trial will test an automated mobile phone-based CM approach that will allow socioeconomically disadvantaged individuals to remotely benefit from financial incentives for smoking cessation. The goal is to see if this will help people quit smoking and if it's cost effective.

Who is the study for?

This trial is for adults over 18 who smoke at least 5 cigarettes daily, want to quit within 7-14 days after joining, and earn below a certain income level. They must not use other tobacco products or have conditions that prevent using nicotine replacement therapy (NRT). A valid ID and U.S. residence proof are required.Check my eligibility

What is being tested?

The study tests an automated mobile phone system offering financial rewards for quitting smoking against standard care with telephone counseling and NRT. Participants' success in quitting will be tracked by remote breath tests confirming no smoking.See study design

What are the potential side effects?

While the trial itself may not directly cause side effects, nicotine replacement therapy can include symptoms like nausea, headaches, difficulty sleeping, or skin irritation where patches are applied.

P3 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

P3 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 26 weeks post-quit-date

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~26 weeks post-quit-date

This trial's timeline: 3 weeks for screening, Varies for treatment, and 26 weeks post-quit-date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Carbon monoxide-verified smoking abstinence

Cost-effectiveness

P3 Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Contingency Management (CM)Experimental Treatment2 Interventions

CM participants will receive standard care in addition to small financial incentives for biochemically-verified abstinence.

Group II: Standard Care (SC)Active Control1 Intervention

Participants randomized to Standard Care will be offered weekly smoking cessation counseling and pharmacotherapy.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,680 Previous Clinical Trials

40,928,052 Total Patients Enrolled

M.D. Anderson Cancer CenterOTHER

2,975 Previous Clinical Trials

1,788,977 Total Patients Enrolled

H. Lee Moffitt Cancer Center and Research InstituteOTHER

543 Previous Clinical Trials

134,950 Total Patients Enrolled

Media Library

Smoking Cessation Research Study Groups: Standard Care (SC), Contingency Management (CM)

Smoking Cessation Clinical Trial 2023: Automated Mobile Contingency Management (CM) Highlights & Side Effects. Trial Name: NCT04881630 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers still enrolling participants in this trial?

"Clinicaltrials.gov indicates that this study is not currently soliciting recruits, as it was posted and last modified on October 31st 2022. However, there are 143 other medical studies seeking participants at the present moment."

Answered by AI